Revolution Medicines closes public offering of 15.7M shares for $323.6M net proceeds

Revolution Medicines, Inc.

Offering of 15,681,818 shares of common stock at $22.00 per share to the public.
Underwriters purchased at $20.68 per share; net proceeds of approx. $323.6M.
Full exercise of underwriters' option; 30-day option period for additional 2M shares.
Company and insiders subject to 60-day lock-up from prospectus date.
Lead underwriters: J.P. Morgan, Cowen, SVB Securities, Guggenheim Securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.